ClinicalTrials.Veeva

Menu

Characteristic of Drug Users Chronic Wound (TOXIPO)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Wound
Drug Use

Study type

Observational

Funder types

Other

Identifiers

NCT03608384
PSS/TOXIPO-SCHMUTZ/ELR

Details and patient eligibility

About

The aim of this study is to describe demographic, clinical, etiological characteristic and evolution of drug addict's chronic wounds .

Enrollment

58 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all drug addict with chronic wound ( evolving at least since 1 month)

Exclusion criteria

  • use following medication inductor of cutaneous ulcer: hydroxycarbamide, gefitinib, cetuximab, sunitinib, sorafenib, pazopanib, gemcitabine, sirolimus, methotrexate, nicorandil .

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems